Skip to main content

Table 2 Demographic and clinical data of control and patient in different age groups

From: Evaluation of the interaction between tumor growth factor-β and interferon type I pathways in patients with COVID-19: focusing on ages 1 to 90 years

Groups

Subjects

Age year

WBC Per µL

Lymphocyte × 100

CRP mg/mL

PT s

PTT s

LDH IU/L

Under 20 years

Control

7.44 ± 6.98

5850.88 ± 1095.3

0.28 ± 0.04

4.57 ± 1.33

11.77 ± 0.83

25.44 ± 1.01

212.77 ± 34.82

n = 9

       

Median

5

6335

0.29

4

12

26

218

Patients

4.54 ± 5.1

7218.18 ± 3982.66

0.17 ± 0.03

23.54 ± 1.36

13.12 ± 0.9

30 ± 7.5

604.54 ± 110.91

n = 11

       

Median

2

5000

0.17

22

13

30

620

p value

0.29

0.33

< 0.0001*

< 0.0001*

0.002*

0.08

< 0.0001*

20–40 years

Control

33.7 ± 4.24

5960.1 ± 1437.4

0.25 ± 0.04

4.66 ± 1.64

11.6 ± 1.26

24.8 ± 1.22

203.13 ± 39.95

n = 10

       

Median

35

5514

0.27

4

12

25

206

Patients

33.63 ± 6

10,354.54 ± 6561.3

0.16 ± 0.05

40.81 ± 20.32

13.32 ± 1.26

35.02 ± 12.27

692.27 ± 332.54

n = 11

       

Median

36

6600

0.16

37

13.1

35

678

p value

0.97

0.052

< 0.0001*

< 0.0001*

0.005*

0.01*

< 0.0001*

40–60 years

Control

48.3 ± 6.05

5264 ± 1495.39

0.25 ± 0.03

6.19 ± 2.19

12 ± 1.33

25.1 ± 0.87

191.68 ± 46.97

n = 10

       

Median

46

4742

0.25

6

12

25

174

Patients

48.87 ± 5.38

5187.5 ± 2699.96

0.19 ± 0.07

45.12 ± 10.66

13.32 ± 1.4

39.5 ± 9.08

888.12 ± 759.89

n = 8

       

Median

47.5

4250

0.21

48

13

38

635

p value

0.83

0.93

0.002*

 < 0.0001*

0.057

< 0.0001*

0.01*

More than 60 years

Control

68.09 ± 5.7

5124.36 ± 1293

0.28 ± 0.05

6.05 ± 2.34

11.36 ± 1.62

25.09 ± 0.94

183.83 ± 40.49

n = 11

       

Median

67

5148

0.29

6

11

25

178

Patients

70.09 ± 9.77

7323.63 ± 4218.4

0.17 ± 0.06

37.81 ± 15.1

13.03 ± 1.41

36.5 ± 7.48

729.18 ± 173.72

n = 11

       

Median

67

6400

0.18

36

12.6

37

715

p value

0.56

0.11

< 0.0001*

< 0.0001*

0.01*

< 0.0001*

< 0.0001*

  1. WBC White blood cell, CRP C-reactive protein, PT Prothrombin time test, PTT Partial thromboplastin time, LDH Lactate dehydrogenase, s Second
  2. *Significant (p < 0.05)